NKG2D Signaling and Host Defense after Mouse Hepatitis Virus Infection of the Central Nervous System

  • Kevin B. Walsh
  • Melissa B. Lodoen
  • Lewis L. Lanier
  • Thomas E. Lane
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 581)


Natural Killer Cell NKG2D Ligand Mouse Hepatitis Virus NKG2D Receptor Efficient Immune Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    D. H. Raulet, Roles of the NKG2D immunoreceptor and its ligands, Nat. Rev. Immunol. 3, 781-790 (2003).CrossRefPubMedGoogle Scholar
  2. 2.
    A. Diefenbach, A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet, Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages, Nat. Immunol. 1, 119-126 (2000).CrossRefPubMedGoogle Scholar
  3. 3.
    A. M. Jamieson, A. Diefenbach, C. W. McMahon, N. Xiong, J. R. Carlyle, and D. H. Raulet, The role of the NKG2D immunoreceptor in immune cell activation and natural killing, Immunity 17, 19-29 (2002).CrossRefPubMedGoogle Scholar
  4. 4.
    A. Cerwenka, A. B. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Phillips, and L. L. Lanier, Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice, Immunity 12, 721-727 (2000).CrossRefPubMedGoogle Scholar
  5. 5.
    L. N. Carayannopoulos, O. V. Naidenko, D. H. Fremont, and W. M. Yokoyama, Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D, J. Immunol. 169, 4079-4083 (2002).PubMedGoogle Scholar
  6. 6.
    S. R. Perlman, T. E. Lane, and M. J. Buchmeier, in: Effects of Microbes on the Immune System, edited by M. W. Cunningham and R. S. Fujinami (Lippincott Williams & Wilkins, Philadelphia, 1999), pp. 331-348.Google Scholar
  7. 7.
    F. S. Cheever, J. B. Daniels, A. M. Pappenheimer, and O. T. Bailey, A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin, J. Exp. Med. 90, 181-194 (1949).CrossRefPubMedGoogle Scholar
  8. 8.
    J. S. Williamson and S. A. Stohlman, Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells, J. Virol. 64, 4589-4592 (1990).PubMedGoogle Scholar
  9. 9.
    B. Parra, D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman, IFN-gamma is required for viral clearance from central nervous system oligodendroglia, J. Immunol. 162, 1641-1647 (1999).PubMedGoogle Scholar
  10. 10.
    M. T. Lin, S. A. Stohlman, and D. R. Hinton, Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis, J. Virol. 71, 383-391 (1997).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Kevin B. Walsh
    • 1
  • Melissa B. Lodoen
    • 2
  • Lewis L. Lanier
    • 3
  • Thomas E. Lane
    • 4
  1. 1.University of CaliforniaIrvineUSA
  2. 2.University of CaliforniaSan FranciscoUSA
  3. 3.University of CaliforniaSan FranciscoUSA
  4. 4.University of CaliforniaIrvineUSA

Personalised recommendations